The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksARDN.L Regulatory News (ARDN)

  • There is currently no data for ARDN

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Trading Update

1 May 2020 07:00

RNS Number : 5287L
Arden Partners plc
01 May 2020
 

Arden Partners plc

("Arden" or the "Company")

 

Trading Update

 

Arden is today issuing a trading update in respect of the six-month period ended 30 April 2020.

 

Arden made a good start to the six-month trading period despite it encompassing the elevated political uncertainty around Brexit and then the General Election. Trading towards the end of the period has been impacted by the significant global market declines in reaction to the COVID-19 pandemic.

 

Compared to the performance in the six months ended 30 April 2019, we anticipate materially higher corporate finance revenues, higher retainer levels but lower equity commissions. The equity trading operation suffered material losses as markets fell in response to COVID-19.

 

The Board has implemented steps to reduce the Company's cost base. As a result, the Company's current annual cost base is anticipated to be more than 25% lower than last year. The measures taken include salary and fee sacrifices for all Board members and certain senior employees of in excess of 40% of salary; salary sacrifices for all other employees; the furloughing of a number of staff and the cancellation or deferral of all discretionary expenditure. Arden will also defer the payment of VAT in line with the government's proposals. The Board will continue to take action to reduce costs and minimise the financial impact of the uncertainty caused by COVID 19.  

 

Before taking into account the equity trading book losses, Arden expects to report a profit for the six-month period. After taking into account the equity trading book losses, Arden expects to report a reduced loss for the period compared to the prior year.

 

The Company has a strong balance sheet, with cash and cash equivalent resources well in excess of its regulatory requirements.   

 

Operationally, we responded to COVID-19 promptly and successfully implemented a comprehensive remote working capability, which has enabled us to ensure both the wellbeing of our staff and the ability to continue servicing our clients as normal. The Company is fully operational and continues to operate as normal. Due to the quality and flexibility of our people and the strengths of our business, our ability to attract and win new high-quality corporate clients remains strong. We continue to sign up quality clients and have a good pipeline going forward.

 

We are working closely with our corporate clients to assess the disruption caused by COVID-19 and, where possible, assist them in protecting their businesses and continuing to implement their strategies. Our aim is to fully support all corporate and institutional clients during these unprecedented times.

 

Mark Ansell, Chairman, commented:

 

"The COVID-19 crisis has presented unprecedented challenges to our business. However, it remains in a strong financial position and we have taken the necessary actions to enable us to confront the current market environment without harming our ability to fully service our clients. The Board is indebted to the Company's employees for their hard work and ongoing support in light of these challenges.

 

The Board's priorities remain to protect the Company's balance sheet and to deliver on our stated growth strategy."

 

 

For further information, please contact:

 

Arden Partners plc

 

020 7614 5900

Donald Brown - Chief Executive Officer

James Reed-Daunter - Executive Director

Steve Douglas - Group Finance Director

 

GCA Altium Limited (NOMAD)

 

020 7484 4040

Tim Richardson

 

 

Notes for editors:

 

Arden is a dedicated corporate adviser and multi-service stockbroker to small and mid-cap companies in the UK and their investors.

 

The absolute core of our business is the effective management of the needs of our significant and growing base of corporate clients, and the effective support of their relationships with existing and potential shareholders. 

 

These relationships are enhanced by the quality of our corporate finance advice and industry research, and the strong market presence of our sales and trading teams.

 

Our corporate finance capabilities encompass M&A, corporate finance advisory, broking and Sponsor and NOMAD services. We represent our clients in private transactions and AIM and Main Market share issues.

 

Our research is designed to be sector focused, concentrating on top down thematic trends which highlight companies giving investors an exposure to the real growth areas of the small-cap and AIM markets.

 

It is the job of the sales team to keep institutions abreast of these themes and stock ideas. When there is a requirement for our corporate clients to raise money to fulfil their growth ambitions, the sales team is in a strong position to effect this, with its entrenched relationships with the UK institutional and non-institutional markets.

 

Our market making and trading teams provide liquidity in the shares of our corporate clients. We also trade the shares of non-client corporates on behalf of institutions.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
TSTKKKBNBBKDQQN
Date   Source Headline
4th Jun 201912:40 pmRNSForm 8.5 (EPT/NON-RI)
24th May 201911:55 amRNSForm 8.5 (EPT/NON-RI)
13th May 201910:56 amRNSDirector/PDMR Shareholding
12th Apr 201910:12 amRNSDirector/PDMR Shareholding
20th Mar 20194:34 pmRNSResult of AGM
20th Mar 20197:00 amRNSAGM Statement
13th Mar 20198:58 amRNSDirector/PDMR Shareholding
12th Feb 20191:37 pmRNSDirector/PDMR Shareholding
12th Feb 20191:33 pmRNSBlock Listing Six Monthly Return
6th Feb 20192:22 pmRNSPosting of Accounts and Notice of AGM
29th Jan 20199:15 amRNSDirector/PDMR Shareholding
24th Jan 20197:00 amRNSAudited Results for the Year Ended 31 October 2018
14th Jan 20191:52 pmRNSDirector/PDMR Shareholding
14th Jan 20197:00 amRNSLaunch of Arden Wealth Management
11th Jan 201911:56 amRNSConfirmation of Board Appointment
4th Jan 201911:13 amRNSConfirmation of Board appointment
12th Dec 20182:07 pmRNSDirector/PDMR Shareholding
15th Nov 201811:07 amRNSDirector/PDMR Shareholding
1st Nov 20187:00 amRNSBoard Appointments
31st Oct 20184:50 pmRNSTotal Voting Rights
29th Oct 201810:10 amRNSTransaction in Own Shares
26th Oct 20187:00 amRNSTransaction in Own Shares
22nd Oct 201812:46 pmRNSDirector/PDMR Shareholding
10th Oct 201811:50 amRNSForm 8.5 (EPT/NON-RI)
10th Oct 201810:03 amRNSForm 8.5 (EPT/NON-RI) (amended)
28th Sep 201811:50 amRNSForm 8.5 (EPT/NON-RI)
17th Sep 20183:59 pmRNSDirector/PDMR Shareholding
14th Aug 20188:52 amRNSBlock Listing Six Monthly Return
30th Jul 20187:00 amRNSInterim Results - Six Months Ended 30 April 2018
24th May 20187:00 amRNSBoard Change
18th May 201811:50 amRNSForm 8.5 (EPT/NON-RI)
17th May 201811:50 amRNSForm 8.5 (EPT/NON-RI)
16th May 201811:50 amRNSForm 8.5 (EPT/NON-RI)
15th May 201811:50 amRNSForm 8.5 (EPT/NON-RI)
14th May 201811:57 amRNSForm 8.5 (EPT/NON-RI)
11th May 201811:50 amRNSForm 8.5 (EPT/NON-RI)
10th May 201811:50 amRNSForm 8.5 (EPT/NON-RI)
9th May 201811:57 amRNSForm 8.5 (EPT/NON-RI)
8th May 20181:22 pmRNSForm 8.5 (EPT/NON-RI)
4th May 201811:50 amRNSForm 8.5 (EPT/NON-RI)
3rd May 201811:50 amRNSForm 8.5 (EPT/NON-RI)
2nd May 201811:50 amRNSForm 8.5 (EPT/NON-RI)
1st May 201811:50 amRNSForm 8.5 (EPT/NON-RI)
30th Apr 201811:50 amRNSForm 8.5 (EPT/NON-RI)
27th Apr 201811:50 amRNSForm 8.5 (EPT/NON-RI)
26th Apr 201812:54 pmRNSForm 8.5 (EPT/NON-RI)
18th Apr 201811:50 amRNSForm 8.5 (EPT/NON-RI)
16th Apr 201811:50 amRNSForm 8.5 (EPT/NON-RI)
13th Apr 201811:50 amRNSForm 8.5 (EPT/NON-RI)
12th Apr 201811:50 amRNSForm 8.5 (EPT/NON-RI)

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.